Status: current, Primitive. Date: 31-Aug 2012. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 241611000036116 | Revasc (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 241621000036111 | Revasc | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Revasc | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Revasc (desirudin 15 mg) powder for injection [10 x 15 mg vials] (&) (inert substance) diluent [10 x 1 mL ampoules], 1 pack (containered trade product pack) | has TP | True | Revasc | Inferred relationship | Some | |
| Revasc (desirudin 15 mg) powder for injection, 15 mg vial | Is a | True | Revasc | Inferred relationship | Some | |
| Revasc (inert substance) diluent, 1 mL ampoule | Is a | True | Revasc | Inferred relationship | Some | |
| Revasc (10 x 15 mg vials, 10 x 1 mL inert diluent ampoules), 1 pack | has TP | True | Revasc | Inferred relationship | Some | |
| Revasc (2 x 15 mg vials, 2 x 1 mL inert diluent ampoules), 1 pack | has TP | True | Revasc | Inferred relationship | Some | |
| Revasc (2 x 15 mg vials, 2 x 1 mL inert diluent ampoules), 1 pack | has TP | True | Revasc | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set
REPLACED BY association reference set
FHIR